Bactrobanmupirocin
According to the FDA label: Mupirocin cream is indicated for the treatment of secondarily infected traumatic skin lesions (up to 10 cm in length or 100 cm 2 in area) due to susceptible isolates of Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogenes) .
13,053 adverse event reports submitted to the FDA (2004–2026)
Top Reported Adverse Events
The most frequently reported events in association with Bactroban in the FAERS database. These are events reported by patients taking this medication, not necessarily caused by it. A single report may include multiple events.
Show these terms with plain-language definitions
Tap any term below for a plain-language definition.
Drug Ineffective 1,457 reports
A report that the medication did not work as expected for the person taking it. This is a reporting category, not a sign the drug is defective. It simply means someone felt it was not helping their condition.
Full definition in the glossary →Off Label Use 945 reports
Using a medication for a condition or in a way that the FDA has not officially approved. This is common and often legal, and a report of it does not mean something went wrong. Doctors sometimes prescribe drugs off label based on their judgment.
Full definition in the glossary →Nausea 905 reports
The feeling of sickness in your stomach that often comes before vomiting.
Full definition in the glossary → See all drugs reporting this event →Pain 890 reports
A general report of physical discomfort, used when no more specific location is given.
Full definition in the glossary →Product Use in Unapproved Indication 832 reports
Using a medication for a condition it is not officially approved to treat. Like off label use, this is a reporting category and does not by itself mean harm occurred.
Full definition in the glossary →Fatigue 779 reports
Extreme tiredness or lack of energy that does not improve with rest.
Full definition in the glossary → See all drugs reporting this event →Macular Degeneration 753 reports
An eye condition that affects central vision, more common with age. It may appear in reports as a condition being treated.
Full definition in the glossary →Headache 728 reports
Pain in the head or upper neck.
Full definition in the glossary → See all drugs reporting this event →Diarrhoea 669 reports
Loose or watery bowel movements, often frequent. Also spelled diarrhea in American English.
Full definition in the glossary → See all drugs reporting this event →Chronic Kidney Disease 578 reports
A long-term, gradual loss of kidney function over months or years.
Full definition in the glossary →Rash 578 reports
An area of irritated, red, or bumpy skin.
Full definition in the glossary → See all drugs reporting this event →Weight Decreased 555 reports
Pruritus 537 reports
Pyrexia 533 reports
The medical term for fever, meaning a raised body temperature.
Full definition in the glossary → See all drugs reporting this event →Dyspnoea 513 reports
Shortness of breath or difficulty breathing. Also spelled dyspnea in American English.
Full definition in the glossary → See all drugs reporting this event →
Ranked by frequency of reports, not severity. The most-reported event is not necessarily the most dangerous or the most common in patients taking this drug.
Who Is Reporting
Demographics of patients in FAERS reports that included this information. Not all reports include patient demographics.
By Sex
View reporter sex data as a table
| Sex | Reports |
|---|---|
| Female | 6,832 |
| Male | 4,096 |
| Unknown | 6 |
By Age Group
View age group data as a table
| Age group | Reports |
|---|---|
| 0-17 | 684 |
| 18-34 | 575 |
| 35-49 | 840 |
| 50-64 | 1,995 |
| 65-74 | 1,673 |
| 75+ | 1,182 |
This shows who filed reports, reflecting who takes this drug and who tends to report, not who is at greatest risk.
Reported Outcomes
Outcomes recorded in FAERS reports that included Bactroban. A single report may involve multiple reactions, each with a different outcome. These categories are defined by FDA reporting guidelines, not by PillSignal.
View outcome data as a table
| Outcome | Reports |
|---|---|
| Non-Serious | 5,578 |
| Other Serious | 5,365 |
| Hospitalization | 3,484 |
| Death | 906 |
| Life-Threatening | 276 |
| Disability | 192 |
Serious outcomes are far more likely to be reported than mild ones, so this overstates how often outcomes are serious. A recorded death does not mean the drug caused it.
Report Volume Over Time
Number of FAERS reports received per quarter for Bactroban. Changes in volume may reflect shifts in prescribing rates, media attention, or reporting behavior, not changes in the medication's safety profile.
View report trend as a table
| Year | Reports |
|---|---|
| 2004 | 13 |
| 2005 | 22 |
| 2006 | 23 |
| 2007 | 30 |
| 2008 | 34 |
| 2009 | 70 |
| 2010 | 90 |
| 2011 | 120 |
| 2012 | 129 |
| 2013 | 125 |
| 2014 | 224 |
| 2015 | 364 |
| 2016 | 734 |
| 2017 | 762 |
| 2018 | 1,161 |
| 2019 | 1,237 |
| 2020 | 1,263 |
| 2021 | 1,289 |
| 2022 | 1,181 |
| 2023 | 1,321 |
| 2024 | 1,239 |
| 2025 | 1,364 |
| 2026 (partial) | 258 |
The steep increase around 2004 reflects the FDA's move to electronic submission, not a change in this drug's safety. Trends track reporting volume, not risk.
Medications commonly reported with Bactroban
In FDA adverse event reports that mention Bactroban, these medications appeared most often in the same report.
- Ergocalciferol (2,966 reports)
- Acetaminophen (2,842 reports)
- Prednisone (2,709 reports)
- Omeprazole (2,148 reports)
- Gabapentin (2,118 reports)
This reflects co-occurrence in submitted reports, not evidence of drug interaction or combined risk. People often report several medications taken for the same condition or for unrelated reasons. Talk to a doctor or pharmacist about your specific medications.
Related Drugs
Other medications with similar adverse event profiles in FDA FAERS reports.
Data Source
This data is sourced from the FDA's Adverse Event Monitoring System (AEMS), formerly FAERS, via the OpenFDA API. PillSignal is not affiliated with the FDA.
View this data on the FDA website →Data last updated: June 2026